Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited)

v3.20.4
Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Retained Earnings / (Accumulated Deficit)
Total
Balance at Dec. 31, 2018 $ 410 $ 3,838,395 $ 1,161,201 $ 5,000,006
Balance (in shares) at Dec. 31, 2018 4,098,712      
Change in the value of common stock subject to possible redemption (as restated) $ 13 (231,610) (231,597)
Change in the value of common stock subject to possible redemption (as restated) (in shares) 128,376      
Net loss (as restated) 231,595 231,595
Balance at Mar. 31, 2019 $ 423 3,606,785 1,392,796 5,000,004
Balance (in shares) at Mar. 31, 2019 4,227,088      
Change in the value of common stock subject to possible redemption (as restated) [1] $ 3 10,830 10,833
Change in the value of common stock subject to possible redemption (as restated) (in shares) [1] 37,203      
Net loss (as restated) (10,830) (10,830)
Balance at Jun. 30, 2019 $ 426 3,617,615 1,381,966 5,000,007
Balance (in shares) at Jun. 30, 2019 4,264,291      
Change in the value of common stock subject to possible redemption (as restated) $ 4 21,787 21,791
Change in the value of common stock subject to possible redemption (as restated) (in shares) 36,298      
Net loss (as restated) (21,790) (21,790)
Balance at Sep. 30, 2019 $ 430 3,639,402 1,360,176 5,000,008
Balance (in shares) at Sep. 30, 2019 4,300,589      
Balance at Dec. 31, 2019 $ 446 3,929,663 1,069,901 5,000,010
Balance (in shares) at Dec. 31, 2019 4,458,149      
Change in the value of common stock subject to possible redemption (as restated) [2] $ 2 217,406 217,408
Change in the value of common stock subject to possible redemption (as restated) (in shares) [2] 21,129      
Net loss (as restated) (217,411) (217,411)
Balance at Mar. 31, 2020 $ 448 4,147,069 852,490 5,000,007
Balance (in shares) at Mar. 31, 2020 4,479,278      
Balance at Dec. 31, 2019 $ 446 3,929,663 1,069,901 5,000,010
Balance (in shares) at Dec. 31, 2019 4,458,149      
Balance at Sep. 30, 2020 $ 547 12,680,301 (7,933,241) 4,747,607
Balance (in shares) at Sep. 30, 2020 5,467,916      
Balance at Mar. 31, 2020 $ 448 4,147,069 852,490 5,000,007
Balance (in shares) at Mar. 31, 2020 4,479,278      
Change in the value of common stock subject to possible redemption (as restated) [2] $ (39) (4,083,569) (4,083,608)
Change in the value of common stock subject to possible redemption (as restated) (in shares) [2] (390,056)      
Issuance of commitment shares and beneficial conversion feature in connection with convertible promissory notes (as restated) $ 105 2,869,892 2,869,997
Issuance of commitment shares and beneficial conversion feature in connection with convertible promissory notes (as restated) (in shares) 1,050,000      
Stock-based compensation   2,625,000   2,625,000
Waiver of deferred underwriting fee 4,025,000 4,025,000
Net loss (as restated) (5,436,388) (5,436,388)
Balance at Jun. 30, 2020 $ 514 9,583,392 (4,583,898) 5,000,008
Balance (in shares) at Jun. 30, 2020 5,139,222      
Change in the value of common stock subject to possible redemption (as restated) $ 23 2,323,704 2,323,727
Change in the value of common stock subject to possible redemption (as restated) (in shares) 228,694      
Issuance of commitment shares and beneficial conversion feature in connection with convertible promissory notes (as restated) $ 10 773,205 773,215
Issuance of commitment shares and beneficial conversion feature in connection with convertible promissory notes (as restated) (in shares) 100,000      
Net loss (as restated) (3,349,343) (3,349,343)
Balance at Sep. 30, 2020 $ 547 $ 12,680,301 $ (7,933,241) $ 4,747,607
Balance (in shares) at Sep. 30, 2020 5,467,916      
[1] Includes the redemption of 5,128,523 shares of common stock on March 5, 2019 and 1,580,762 shares of common stock on June 5, 2019.
[2] Includes the redemption of 67,665 shares of common stock on April 8, 2020.